SCHEMBL12238626

SCHEMBL12238626

CCc1ccccc1C(C)(O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.43
▸ GABRB2 P47870 2/20 0.43
▸ HSP90AA1 P07900 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ RIPK1 Q13546 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TSHR P16473 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12262668 0.79 GABRA1 (0.50) GABRA1GABRB2ALDH1A1CYP2C19CYP3A4
SCHEMBL11311524 0.77 GABRA1 (0.52) GABRA1GABRB2ALDH1A1HSD11B1MAPT
Hydrogen Peroxide SCHEMBL11570368 0.75 GABRA1 (0.50) GABRA1GABRB2ALDH1A1MAPTTSHR
SCHEMBL1521882 0.74 GABRA1 (0.48) GABRA1GABRB2ALDH1A1MAPTTSHR
SCHEMBL16105766 0.74 GABRA1 (0.48) GABRA1GABRB2ALDH1A1MAPTTSHR
SCHEMBL27774934 0.74 GABRA1 (0.48) GABRA1GABRB2ALDH1A1HSD11B1MAPT
SCHEMBL28088611 0.74 GABRA1 (0.48) GABRA1GABRB2HSP90AA1ALDH1A1HSD11B1
SCHEMBL3194195 0.74 GABRA1 (0.48) GABRA1GABRB2ALDH1A1HSD11B1RIPK1
SCHEMBL12238612 0.74 GABRA1 (0.42) GABRA1GABRB2HSP90AA1ALDH1A1CYP2C19
SCHEMBL16943965 0.73 GABRA1 (0.43) GABRA1GABRB2ALDH1A1HSD11B1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309730-B2 Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappab acitivity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-13 — — US disclosed
US-20110263494-A1 NONSTEROIDAL COMPOUNDS USEFUL AS MODULATORS OF GLUCOCORTICOID RECEPTOR AP-1 AND/OR NF-KAPPAB ACITIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2011-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263494-A1 NONSTEROIDAL COMPOUNDS USEFUL AS MODULATORS OF GLUCOCORTICOID RECEPTOR AP-1 AND/OR NF-KAPPAB ACITIVITY AND USE THEREOF NFKBIA, RELA, NR3C1 GABRA1 646/4885GABRB2 731/4885HSP90AA1 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback